Stereotaxis, Inc. (STXS) stock price, news, quote and history

First-in-Human Coronary Intervention Study Results of Robocath’s Next-Generation Robotic System Highlighted at TCT

20 robotic heart procedures had no device-related adverse events.

Stereotaxis Announces 100% Clinical Success Rate For Its Robocath's Robotic System At Transcatheter Cardiovascular Therapeutics Conference; Technical Success Reported At 95%

Canon Medical and Stereotaxis Collaborate to Advance Robotic Electrophysiology

Canon imaging will be offered alongside a robot designed for existing labs, with no construction.

Canon Medical Systems, Stereotaxis Announce Technology Compatibility And Commercial Collaboration To Pair Alphenix Interventional Imaging Platform With Genesisx Robotic Magnetic Navigation System

Stereotaxis Announces First Robotic Magnetic Navigation System in Latvia

Stereotaxis Says Pauls Stradiņš Clinical University Hospital In Latvia, Establishes Robotic Center For Treatment Of Cardiac Arrhythmias In Latvia And Treats Initial Patients With Genesis Robotic Magnetic Navigation System

Stereotaxis to Report Third Quarter 2026 Financial Results on November 10, 2026

Global Electrophysiology Devices Market Size, Share, Growth, and Forecast 2026-2035 | Pulsed Field Ablation and 3D Mapping Fuel 12.40% CAGR to USD 30.16 Billion by 2035

ISRG Is Expanding Beyond Surgery: Here's Why the GI Opportunity Matters

Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society’s HRX 2026

Stereotaxis: A Real Product Story, But The Stock Already Prices In Success (NYSE:STXS)

University of Szeged Celebrates Strongest First Month of Robotic Cardiology Program